Clarification of P-glycoprotein inhibition-related drug-drug interaction risks based on a literature search of the clinical information.

about

Role of P-glycoprotein and permeability upon the brain distribution and pharmacodynamics of etamicastat: a comparison with nepicastat.Comparative pharmacokinetics study of anastrozole after single administration and combination with celecoxib.

P2860

Q42476216-71E03617-D0C9-4DAB-9319-E70AA4179672 Q47803989-01D84071-69A9-4715-9C4A-E39F341F8BCB

P2860

Clarification of P-glycoprotein inhibition-related drug-drug interaction risks based on a literature search of the clinical information.

Item

http://www.wikidata.org/entity/Q50668713

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Clarification of P-glycoprotei ...... h of the clinical information.

@en

Clarification of P-glycoprotei ...... h of the clinical information.

@nl

type

Item

label

Clarification of P-glycoprotei ...... h of the clinical information.

@en

Clarification of P-glycoprotei ...... h of the clinical information.

@nl

prefLabel

Clarification of P-glycoprotei ...... h of the clinical information.

@en

Clarification of P-glycoprotei ...... h of the clinical information.

@nl

P1476

Clarification of P-glycoprotei ...... h of the clinical information.

@en

P2093

Teruaki Okuda

http://www.w3.org/2001/XMLSchema#string

Yasushi Fujioka

http://www.w3.org/2001/XMLSchema#string

Yukari Umeyama

http://www.w3.org/2001/XMLSchema#string

P2860

Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics

Effect of omeprazole on the pharmacokinetics of saquinavir-500 mg formulation with ritonavir in healthy male and female volunteers

Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administration

Membrane transporters in drug development

Increased drug delivery to the brain by P-glycoprotein inhibition.

Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel.

The utility of in vitro data in making accurate predictions of human P-glycoprotein-mediated drug-drug interactions: a case study for AZD5672.

A phenotype-genotype approach to predicting CYP450 and P-glycoprotein drug interactions with the mixed inhibitor/inducer tipranavir/ritonavir

Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin.

Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1.

P304

1135-1144

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/00498254.2014.928958

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24937160

http://www.w3.org/2001/XMLSchema#string

Clarification of P-glycoprotein inhibition-related drug-drug interaction risks based on a literature search of the clinical information.

about

P2860

P2860

Clarification of P-glycoprotein inhibition-related drug-drug interaction risks based on a literature search of the clinical information.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698